MHRA announces new way to pay

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that a new ‘Pay on Invoice’ method has been introduced for paying medicines licenses, clinical trials and clinical investigations.

From 1 April those making applications will no longer need to attach proof of payment which it is hoped will streamline the payment process, making it simpler, easier and quicker.

According to a statement for the MHRA, the benefits of the new process include removing the need to work out complex fees and reducing the chance of applications being rejected for incorrect payment details. Additionally the simplified payment process should result in fewer delays and make it easier for companies to reconcile financial records and accounts.

Overall the process is aimed at saving companies time and money.

Richard Humphreys, MHRA’s deputy director of Finance said: “We have listened to our customers and launched this new project in order to make the process of payment much easier and quicker.

“We hope the new process will reduce the regulatory burden and reduce unnecessary delays.

“As with everything we do, we welcome your feedback.”

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho